Regulatory and Stewardship, Corteva Agriscience, Indianapolis, Indiana, USA.
Regulatory and Stewardship, Corteva Agriscience, Johnston, Iowa, USA.
GM Crops Food. 2022 Dec 31;13(1):126-130. doi: 10.1080/21645698.2022.2093552.
The current science on food allergy supports the dual allergen exposure hypothesis where sensitization to allergenic proteins is favored by dermal and inhalation exposure, and tolerization against allergy is favored by exposure in the gut. This hypothesis is bolstered by the epidemiological evidence showing that regions where children are exposed early in life to allergenic foods have lower rates of allergy. This led medical experts to replace the previous recommendation to exclude commonly allergenic foods from the diets of young children with the current recommendation that such foods be introduced to children early in life. Past beliefs that lowering gut exposure would reduce the likelihood that a protein would be allergenic led regulators and risk assessors to consider digestively stable proteins to be of greater allergenic risk. This resulted in international guidance and government regulations for newly expressed proteins in genetically engineered crops that aligned with this belief. Despite empirical results showing that allergens are no more digestively stable than non-allergens, and that gut exposure favors tolerization over sensitization, regulations have not come into alignment with the current science prompting developers to continue to engineer proteins for increased digestibility. In some rare cases, this could potentially increase sensitization risk.
目前的食物过敏科学支持双重过敏原暴露假说,即皮肤和吸入暴露有利于过敏原蛋白致敏,而肠道暴露有利于过敏耐受。这一假说得到了流行病学证据的支持,这些证据表明,儿童在生命早期接触过敏原食物的地区,过敏的发生率较低。这导致医学专家将以前建议将常见的过敏原食物从幼儿饮食中排除的建议改为目前的建议,即应尽早向儿童引入这些食物。过去认为降低肠道暴露会降低蛋白质成为过敏原的可能性,这导致监管机构和风险评估人员认为消化稳定的蛋白质具有更大的致敏风险。这导致国际上对转基因作物中新表达的蛋白质的指导方针和政府法规与这一观点一致。尽管有经验结果表明过敏原并不比非过敏原更具消化稳定性,而且肠道暴露有利于耐受而不是致敏,但法规并未与当前科学保持一致,这促使开发者继续为提高消化率而设计蛋白质。在某些罕见情况下,这可能会增加致敏风险。